GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | EPO | decreases expression | ISO | Epo (Rattus norvegicus) | 6480464 | CTD | Streptozocin results in decreased expression of EPO protein | PMID:20821229 | EPO | increases expression | ISO | Epo (Rattus norvegicus) | 6480464 | CTD | Streptozocin results in increased expression of EPO mRNA | PMID:19958114 PMID:20821229 | EPO | multiple interactions | ISO | Epo (Rattus norvegicus) | 6480464 | CTD | [Dietary Fats co-treated with Streptozocin] results in decreased expression of EPO protein; dapagliflozin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of EPO protein]; Enalapril inhibits the reaction [Streptozocin results in increased expression of EPO mRNA]; Simvastatin inhibits the reaction [Streptozocin results in decreased expression of EPO protein]; Simvastatin inhibits the reaction [Streptozocin results in increased expression of EPO mRNA] | PMID:19958114 PMID:20821229 PMID:34391751 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |